If you develop AML subsequent to treatment for Multiple Myeloma- treatment included stem cell transplant & revlimid, does physician report this to FDA for statistical purposes? Should it be reported?
It is not unusual to form a second type of cancer along with or after treatment for multiple myeloma. The myeloma severely depletes your immune system, making it easy for other forms of cancer to grow. Your immune system is too compromised to fight off other cancer cells. I get Hizentra (Immunoglobulin replacement) therapy every week for my myeloma, as well as a quarterly infusion of Zometa, a bone builder. Did you get your own stem cells back or those of a donor? I know that donor material is treated and tested very stringently, but I wonder if your transplanted stem cells could have contained AML cells. Perhaps you can ask your doctor if that is a possibility. All it would take is one cancer cell to multiply due to your compromised immune system. You have my best wishes for a speedy and complete recovery.
- Revlimid Information for Consumers
- Revlimid Information for Healthcare Professionals (includes dosage details)
- Side Effects of Revlimid (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Updated 13 Jul 2017 • 4 answers
Updated 13 Jul 2017 • 2 answers
Updated 14 May 2013 • 1 answer
Updated 17 Aug 2015 • 1 answer
Updated 19 Nov 2015 • 4 answers